BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38844715)

  • 1. Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue.
    Vasen HF; Canto MI; Goggins M
    Fam Cancer; 2024 Jun; ():. PubMed ID: 38844715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary pancreatic cancer.
    Klatte DCF; Wallace MB; Löhr M; Bruno MJ; van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2022; 58-59():101783. PubMed ID: 35988957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Goggins M; Overbeek KA; Brand R; Syngal S; Del Chiaro M; Bartsch DK; Bassi C; Carrato A; Farrell J; Fishman EK; Fockens P; Gress TM; van Hooft JE; Hruban RH; Kastrinos F; Klein A; Lennon AM; Lucas A; Park W; Rustgi A; Simeone D; Stoffel E; Vasen HFA; Cahen DL; Canto MI; Bruno M;
    Gut; 2020 Jan; 69(1):7-17. PubMed ID: 31672839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes.
    Ardeshna DR; Rangwani S; Cao T; Pawlik TM; Stanich PP; Krishna SG
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals.
    Labiner AJ; Aronson A; Lucas AL
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):929-942. PubMed ID: 36265991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
    Dudley B; Brand RE
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary Pancreatic Cancer Syndromes.
    Connor AA; Gallinger S
    Surg Oncol Clin N Am; 2015 Oct; 24(4):733-64. PubMed ID: 26363539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Screening Strategies for Pancreatic Cancer.
    Vanek P; Urban O; Zoundjiekpon V; Falt P
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreas in Hereditary Syndromes: Cross-sectional Imaging Spectrum.
    Katabathina VS; Buddha S; Rajebi H; Shah JN; Morani AC; Lubner MG; Dasyam A; Nazarullah A; Menias CO; Prasad SR
    Radiographics; 2021; 41(4):1082-1102. PubMed ID: 34143711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pancreatic cancer-screening or surveillance?].
    Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
    Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor lesions in familial and hereditary pancreatic cancer.
    Pflüger MJ; Brosens LAA; Hruban RH
    Fam Cancer; 2024 Feb; ():. PubMed ID: 38319536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of early-onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes.
    Eguchi H; Kobayashi S; Gotoh K; Noda T; Doki Y
    Ann Gastroenterol Surg; 2020 May; 4(3):229-233. PubMed ID: 32490337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
    Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
    Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer.
    Hruban RH; Canto MI; Yeo CJ
    Dig Dis; 2001; 19(1):76-84. PubMed ID: 11385254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.